Corrigendum to “Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC” [J. Eur. Paediatr. Neurol. 20 (2) (2016) 203–211, (S1090379815002160), (10.1016/j.ejpn.2015.12.005)];Early onset epileptic encephalopathy or genetically determined encephalopathy with early onset epilepsy? Lessons learned from TSC

European Journal of Paediatric Neurology

Volumn 20, Issue 2, 2016, Pages 203-211

  Curatolo, Paolo ^a   Aronica, Eleonora ^b,c,d   Jansen, Anna ^e   Jansen, Floor ^f   Kotulska, Katarzyna ^g   Lagae, Lieven ^h   Moavero, Romina ^a,i   Jozwiak, Sergiusz ^j  

^a TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c STICHTING EPILEPSIE INSTELLINGEN NEDERLAND SEIN   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

^e UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

^f UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^g CHILDREN'S MEMORIAL HEALTH INSTITUTE   (Poland)

^h UNIVERSITY HOSPITALS LEUVEN   (Belgium)

ⁱ BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^j MEDICAL UNIVERSITY OF WARSAW   (Poland)

more..

Author keywords

Epileptic encephalopathy; Genetics; mTOR; Tuberous sclerosis; Vigabatrin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; MTOR PROTEIN, HUMAN; TARGET OF RAPAMYCIN KINASE;

BRAIN; BRAIN DISEASE; CELL STRUCTURE; EPILEPSY; EPILEPTIC ENCEPHALOPATHY; EXCITATION; GENE; GENE MUTATION; GENETICS; HUMAN; ITALY; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; REVIEW; SEIZURE; SYNAPTOGENESIS; THEORY; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX GENE; ANIMAL; BRAIN DISEASES; COMPLICATION; FEMALE; INFANT; MALE;

ANIMALS; BRAIN DISEASES; EPILEPSY; FEMALE; HUMANS; INFANT; MALE; SEIZURES; TOR SERINE-THREONINE KINASES; TUBEROUS SCLEROSIS;

EID: 84957437907     PISSN: 10903798     EISSN: 15322130     Source Type: Journal    
DOI: 10.1016/j.ejpn.2022.09.001     Document Type: Erratum

References (71)

1. S. Abdijadid, G.W. Mathern, M.S. Levine, and C. Cepeda Basic mechanisms of epileptogenesis in pediatric cortical dysplasia CNS Neurosci Ther 21 2015 92 103
2. E. Abs, S.M. Goorden, J. Schreiber, I.E. Overwater, M. Hoogeveen-Westerveld, C.F. Bruinsma, E. Aganovic, N.Z. Borgesius, M. Nellist, and Y. Elgersma TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice Ann Neurol 74 2013 569 579
3. S. Anderl, M. Freeland, D.J. Kwiatkowski, and J. Goto Therapeutic value of prenatal rapamycin treatment in a mouse brain model of tuberous sclerosis complex Hum Mol Genet 20 2011 4597 4604
4. E. Aronica, and P.B. Crino Epilepsy related to developmental tumors and malformations of cortical development Neurotherapeutics 11 2014 251 268
5. K.S. Au, A.T. Williams, E.S. Roach, L. Batchelor, S.P. Sparagana, M.R. Delgado, J.W. Wheless, J.E. Baumgartner, B.B. Roa, C.M. Wilson, T.K. Smith-Knuppel, M.Y. Cheung, V.H. Whittemore, T.M. King, and H. Northrup Genotype/phenotype correlation in 325 individuals referred for a diagnosis of tuberous sclerosis complex in the United States Genet Med 9 2007 88 100
6. A.T. Berg, S.F. Berkovic, M.J. Brodie, J. Buchhalter, J.H. Cross, W. van Emde Boas, J. Engel, J. French, T.A. Glauser, G.W. Mathern, S.L. Moshe, D. Nordli, P. Plouin, and I.E. Scheffer Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE Commission on Classification and Terminology, 2005-2009 Epilepsia 51 2010 676 685
7. K. Boer, P.B. Crino, J.A. Gorter, M. Nellist, F.E. Jansen, W.G. Spliet, P.C. van Rijen, F.R. Wittink, T.M. Breit, D. Troost, W.J. Wadman, and E. Aronica Gene expression analysis of tuberous sclerosis complex cortical tubers reveals increased expression of adhesion and inflammatory factors Brain Pathol 20 2010 704 719
8. P.F. Bolton, and P.D. Griffiths Association of tuberous sclerosis of temporal lobes with autism and atypical autism Lancet 349 1997 392 395
9. R. Bombardieri, M. Pinci, R. Moavero, C. Cerminara, and P. Curatolo Early control of seizures improves long-term outcome in children with tuberous sclerosis complex Eur J Paediatr Neurol 14 2010 146 149
10. S. Boronat, E.A. Shaaya, C.M. Doherty, P. Caruso, and E.A. Thiele Tuberous sclerosis complex without tubers and subependymal nodules: a phenotype-genotype study Clin Genet 86 2014 149 154
11. C. Cepeda, J.Y. Chen, J.Y. Wu, R.S. Fisher, H.V. Vinters, G.W. Mathern, and M.S. Levine Pacemaker GABA synaptic activity may contribute to network synchronization in pediatric cortical dysplasia Neurobiol Dis 62 2014 208 217
12. Y.J. Choi, A. Di Nardo, I. Kramvis, L. Meikle, D.J. Kwiatkowski, M. Sahin, and X. He Tuberous sclerosis complex proteins control axon formation Genes Dev 22 2008 2485 2495
13. C.J. Chu-Shore, P. Major, S. Camposano, D. Muzykewicz, and E.A. Thiele The natural history of epilepsy in tuberous sclerosis complex Epilepsia 51 2010 1236 1241
14. P.B. Crino mTOR: a pathogenic signaling pathway in developmental brain malformations Trends Mol Med 17 2011 734 742
15. P.B. Crino Evolving neurobiology of tuberous sclerosis complex Acta Neuropathol 125 2013 317 332
16. P. Curatolo, R. Cusmai, F. Cortesi, C. Chiron, I. Jambaque, and O. Dulac Neuropsychiatric aspects of tuberous sclerosis Ann N Y Acad Sci 615 1991 8 16
17. P. Curatolo, S. Jozwiak, R. Nabbout on behalf of the participants of the TSC Consensus Meeting for SEGA and Epilepsy Management Management of epilepsy associated with tuberous sclerosis complex (TSC): clinical recommendations Eur J Paediatr Neurol 16 2012 582 586
18. P. Curatolo, R. Moavero, and P.J. de Vries Neurological and neuropsychiatric aspects of tuberous sclerosis complex Lancet Neurol 14 2015 733 745
19. R. Cusmai, R. Moavero, R. Bombardieri, F. Vigevano, and P. Curatolo Long-term neurological outcome in children with early-onset epilepsy associated with tuberous sclerosis Epilepsy Behav 22 2011 735 739
20. S.L. Dabora, S. Jozwiak, D.N. Franz, P.S. Roberts, A. Nieto, J. Chung, Y.S. Choy, M.P. Reeve, E. Thiele, J.C. Egelhoff, J. Kasprzyk-Obara, D. Domanska-Pakiela, and D.J. Kwiatkowski Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs Am J Hum Genet 68 2001 64 80
21. P.J. de Vries, and C.J. Howe The tuberous sclerosis complex proteins-a GRIPP on cognition and neurodevelopment Trends Mol Med 13 2007 319 326
22. D. Domanska-Pakiela, M. Kaczorowska, E. Jurkiewicz, K. Kotulska, D. Dunin-Wasowicz, and S. Jozwiak EEG abnormalities preceding the epilepsy onset in tuberous sclerosis complex patients - a prospective study of 5 patients Eur J Paediatr Neurol 18 4 2014 458 468
23. D. Ehninger, S. Han, C. Shilyansky, Y. Zhou, W. Li, D.J. Kwiatkowski, V. Ramesh, and A.J. Silva Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis Nat Med 14 2008 843 848
24. T.T. Gipson, G. Gerner, M.A. Wilson, M.E. Blue, and M.V. Johnston Potential for treatment of severe autism in tuberous sclerosis complex World J Clin Pediatr 2 2013 16 25
25. M.R. Gomez, N.L. Kuntz, and B.F. Westmoreland Tuberous sclerosis, early onset of seizures, and mental subnormality: study of discordant homozygous twins Neurology 32 1982 604 611
26. S.M. Goorden, G.M. van Woerden, L. van der Weerd, J.P. Cheadle, and Y. Elgersma Cognitive deficits in Tsc1+/- mice in the absence of cerebral lesions and seizures Ann Neurol 62 2007 648 655
27. I. Goyer, N. Dahdah, and P. Major Use of mTOR inhibitor everolimus in three neonates for treatment of tumors associated with tuberous sclerosis complex Pediatr Neurol 52 2015 450 453
28. A. Humphrey, B.G. Neville, A. Clarke, and P.F. Bolton Autistic regression associated with seizure onset in an infant with tuberous sclerosis Dev Med Child Neurol 48 2006 609 611
29. K. Im, B. Ahtam, D. Haehn, J.M. Peters, S.K. Warfield, M. Sahin, and P. Ellen Grant Altered structural brain networks in tuberous sclerosis complex Cereb Cortex 2015 [Epub ahead of print]
30. A. Iyer, A. Prabowo, J. Anink, W.G. Spliet, P.C. van Rijen, and E. Aronica Cell injury and premature neurodegeneration in focal malformations of cortical development Brain Pathol 24 2014 1 17
31. F.E. Jansen, K.L. Vincken, A. Algra, P. Anbeek, O. Braams, M. Nellist, B.A. Zonnenberg, A. Jennekens-Schinkel, A. van den Ouweland, D. Halley, A.C. van Huffelen, and O. van Nieuwenhuizen Cognitive impairment in tuberous sclerosis complex is a multifactorial condition Neurology 70 2008 916 923
32. S.S. Jeste, M. Sahin, P. Bolton, G.B. Ploubidis, and A. Humphrey Characterization of autism in young children with tuberous sclerosis complex J Child Neurol 23 2008 520 525
33. C. Joinson, F.J. O'Callaghan, J.P. Osborne, C. Martyn, T. Harris, and P.F. Bolton Learning disability and epilepsy in an epidemiological sample of individuals with tuberous sclerosis complex Psychol Med 33 2003 335 344
34. S. Jozwiak, K. Kotulska, D. Domanska-Pakiela, B. Lojszczyk, M. Syczewska, D. Chmielewski, D. Dunin-Wasowicz, T. Kmiec, J. Szymkiewicz-Dangel, M. Kornacka, W. Kawalec, D. Kuczynski, J. Borkowska, K. Tomaszek, E. Jurkiewicz, and M. Respondek-Liberska Antiepileptic treatment before the onset of seizures reduces epilepsy severity and risk of mental retardation in infants with tuberous sclerosis complex Eur J Paediatr Neurol 15 2011 424 431
35. K. Kotulska, E. Jurkiewicz, D. Domanska-Pakiela, W. Grajkowska, M. Mandera, J. Borkowska, and S. Jozwiak Epilepsy in newborns with tuberous sclerosis complex Eur J Paediatr Neurol 18 2014 714 721
36. D.J. Kwiatkowski, and B.D. Manning Molecular basis of giant cells in tuberous sclerosis complex N Engl J Med 371 2014 778 780
37. F. Lebrun-Julien, L. Bachmann, C. Norrmen, M. Trotzmuller, H. Kofeler, M.A. Ruegg, M.N. Hall, and U. Suter Balanced mTORC1 activity in oligodendrocytes is required for accurate CNS myelination J Neurosci 34 2014 8432 8448
38. W.W. Lewis, M. Sahin, B. Scherrer, J.M. Peters, R.O. Suarez, V.K. Vogel-Farley, S.S. Jeste, M.C. Gregas, S.P. Prabhu, C.A. Nelson 3rd, and S.K. Warfield Impaired language pathways in tuberous sclerosis complex patients with autism spectrum disorders Cereb Cortex 23 2013 1526 1532
39. N. Lozovaya, and et al. Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model Nat Commun 5 2014 4563
40. L. Marcotte, E. Aronica, M. Baybis, and P.B. Crino Cytoarchitectural alterations are widespread in cerebral cortex in tuberous sclerosis complex Acta Neuropathol 123 2012 685 693
41. J. McMahon, X. Huang, J. Yang, M. Komatsu, Z. Yue, J. Qian, X. Zhu, and Y. Huang Impaired autophagy in neurons after disinhibition of mammalian target of rapamycin and its contribution to epileptogenesis J Neurosci 32 2012 15704 15714
42. V. Napolioni, R. Moavero, and P. Curatolo Recent advances in neurobiology of tuberous sclerosis complex Brain Dev 31 2009 104 113
43. A.L. Numis, P. Major, M.A. Montenegro, D.A. Muzykewicz, M.B. Pulsifer, and E.A. Thiele Identification of risk factors for autism spectrum disorders in tuberous sclerosis complex Neurology 76 2011 981 987
44. T. Okanishi, T. Akiyama, S. Tanaka, E. Mayo, A. Mitsutake, C. Boelman, C. Go, O.C. Snead 3rd, J. Drake, J. Rutka, A. Ochi, and H. Otsubo Interictal high frequency oscillations correlating with seizure outcome in patients with widespread epileptic networks in tuberous sclerosis complex Epilepsia 55 2014 1602 1610
45. J.M. Peters, M. Sahin, V.K. Vogel-Farley, S.S. Jeste, C.A. Nelson 3rd, M.C. Gregas, S.P. Prabhu, B. Scherrer, and S.K. Warfield Loss of white matter microstructural integrity is associated with adverse neurological outcome in tuberous sclerosis complex Acad Radiol 19 2012 17 25
46. A.S. Prabowo, J.J. Anink, M. Lammens, M. Nellist, A.M. van den Ouweland, H. Adle-Biassette, H.B. Sarnat, L. Flores-Sarnat, P.B. Crino, and E. Aronica Fetal brain lesions in tuberous sclerosis Complex: TORC1 activation and inflammation Brain Pathol 23 2013 45 59
47. R.M. Reith, J. McKenna, H. Wu, S.S. Hashmi, S.H. Cho, P.K. Dash, and M.J. Gambello Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex Neurobiol Dis 51 2013 93 103
48. O. Sancak, M. Nellist, M. Goedbloed, P. Elfferich, C. Wouters, A. Maat-Kievit, B. Zonnenberg, S. Verhoef, D. Halley, and A. van den Ouweland Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex Eur J Hum Genet 13 2005 731 741
49. A. Sato, S. Kasai, T. Kobayashi, Y. Takamatsu, O. Hino, K. Ikeda, and M. Mizuguchi Rapamycin reverses impaired social interaction in mouse models of tuberous sclerosis complex Nat Commun 3 2012 1292
50. D.M. Talos, D.J. Kwiatkowski, K. Cordero, P.M. Black, and F.E. Jensen Cell-specific alterations of glutamate receptor expression in tuberous sclerosis complex cortical tubers Ann Neurol 63 2008 454 465
51. D.M. Talos, H. Sun, B. Kosaras, A. Joseph, R.D. Folkerth, A. Poduri, J.R. Madsen, P.M. Black, and F.E. Jensen Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia Ann Neurol 71 2012 539 551
52. S.F. Tavazoie, V.A. Alvarez, D.A. Ridenour, D.J. Kwiatkowski, and B.L. Sabatini Regulation of neuronal morphology and function by the tumor suppressors Tsc1 and Tsc2 Nat Neurosci 8 2005 1727 1734
53. P.T. Tsai, E. Green-Colozzi, J. Goto, S. Anderl, D.J. Kwiatkowski, and M. Sahin Prenatal rapamycin results in early and late behavioral abnormalities in wildtype C57B1/6 mice Behav Genet 41 2013 51 59
54. P.T. Tsai, C. Hull, Y. Chu, E. Greene-Colozzi, A.R. Sadowski, J.M. Leech, J. Steinberg, J.N. Crawley, W.G. Regehr, and M. Sahin Autistic-like behaviour and cerebellar dysfunction in Purkinje cell Tsc1 mutant mice Nature 488 2012 647 651
55. V. Tsai, W.E. Parker, K.A. Orlova, M. Baybis, A.W. Chi, B.D. Berg, J.F. Birnbaum, J. Estevez, K. Okochi, H.B. Sarnat, L. Flores-Sarnat, E. Aronica, and P.B. Crino Fetal brain mTOR signaling activation in tuberous sclerosis complex Cereb Cortex 24 2014 315 327
56. A.M. van Eeghen, L. Ortiz-Teran, J. Johnson, M.B. Pulsifer, E.A. Thiele, and P. Caruso The neuroanatomical phenotype of tuberous sclerosis complex: focus on radial migration lines Neuroradiology 55 2013 1007 1014
57. D.L. Vargas, C. Nascimbene, C. Krishnan, A.W. Zimmerman, and C.A. Pardo Neuroglial activation and neuroinflammation in the brain of patients with autism Ann Neurol 57 2005 67 81
58. C. von der Brelie, R. Waltereit, L. Zhang, H. Beck, and T. Kirschstein Impaired synaptic plasticity in a rat model of tuberous sclerosis Eur J Neurosci 23 2006 686 692
59. R. Waltereit, B. Japs, M. Schneider, P.J. de Vries, and D. Bartsch Epilepsy and Tsc2 haploinsufficiency lead to autistic-like social deficit behaviors in rats Behav Genet 41 2011 364 372
60. Y. Wang, J.S. Greenwood, M.E. Calcagnotto, H.E. Kirsch, N.M. Barbaro, and S.C. Baraban Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1 Ann Neurol 61 2007 139 152
61. S.W. Way, N.S. Rozas, H.C. Wu, J. McKenna 3rd, R.M. Reith, S.S. Hashmi, P.K. Dash, and M.J. Gambello The differential effects of prenatal and/or postnatal rapamycin on neurodevelopmental defects and cognition in a neuroglial mouse model of tuberous sclerosis complex Hum Mol Genet 21 2012 3226 3236
62. T. Weichhart, and M.D. Saemann The multiple facets of mTOR in immunity Trends Immunol 30 2009 218 226
63. R. White, Y. Hua, B. Scheithauer, D.R. Lynch, E.P. Henske, and P.B. Crino Selective alterations in glutamate and GABA receptor subunit mRNA expression in dysplastic neurons and giant cells of cortical tubers Ann Neurol 49 2001 67 78
64. J.Y. Wu, J.M. Peters, M. Goyal, D. Krueger, M. Sahin, H. Northrup, K.S. Au, G. Cutter, and E.M. Bebin Clinical electroencephalographic biomarker for impending epilepsy 2015
65. S.A. Yasin, A.M. Ali, M. Tata, S.R. Picker, G.W. Anderson, E. Latimer-Bowman, S.L. Nicholson, W. Harkness, J.H. Cross, S.M. Paine, and T.S. Jacques mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis Acta Neuropathol 126 2013 207 218
66. L.H. Zeng, Y. Ouyang, V. Gazit, J.R. Cirrito, L.A. Jansen, K.C. Ess, K.A. Yamada, D.F. Wozniak, D.M. Holtzman, D.H. Gutmann, and M. Wong Abnormal glutamate homeostasis and impaired synaptic plasticity and learning in a mouse model of tuberous sclerosis complex Neurobiol Dis 28 2007 184 196
67. L.H. Zeng, L. Xu, D.H. Gutmann, and M. Wong Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex Ann Neurol 63 2008 444 453
68. B. Zhang, S.S. McDaniel, N.R. Rensing, and M. Wong Vigabatrin inhibits seizures and mTOR pathway activation in a mouse model of tuberous sclerosis complex PLoS One 8 2013 e57445
69. B. Zhang, J. Zou, N.R. Rensing, M. Yang, and M. Wong Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex Neurobiol Dis 80 2015 70 79
70. R.S. Yeung, C.D. Katsetos, and A. Klein-Szanto Subependymal astrocytic hamartomas in the Eker rat model of tuberous sclerosis Am J Pathol. 151 5 1997 1477 1486
71. R. Waltereit, H. Welzl, J. Dichgans, H.P. Lipp, W.J. Schmidt, and M. Weller Enhanced episodic-like memory and kindling epilepsy in a rat model of tuberous sclerosis J Neurochem. 96 2 2006 407 413